Udimeb
Business Services · Mexico · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2025 Udimeb, MexicoWebsite
www.udimeb.com.mxRevenue
<$5 MillionIndustry
ZI Rank: 1
About Udimeb
Udimeb Org Chart
Analista Químico
Analista Microbiologico
Responsable De Documentación Operativa (Espec...
Auxiliar
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Udimeb your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if Udimeb has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Udimeb recently announced quarterly report
Check out if Udimeb is spiking on competitors!
Udimeb, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Udimeb had a recent Job posting/layoffs
Product Launch: Get notified when Udimeb launches new products
Congratulate Masked Content for being promoted to Masked Content at Udimeb
Funding: Get notified immidiatlly once Udimeb has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Udimeb as Masked Content
Find 3 more new buyers
Udimeb Tech Stack
A closer look at the technologies used by Udimeb
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Udimeb
UDIMEB is focused on generating and promoting research, development, application, and transfer of technology to create and assess products with high potential to become medications. They aim to advance the pharmaceutical sector through innovative solutions. Their target clients include researchers, healthcare professionals, and pharmaceutical compa... Read More
